Daniel Hermens

Professor Daniel Hermens is a Deputy Director at the Thompson Institute, University of the Sunshine Coast (UniSC), leading the Youth Mental Health and Neurobiology program. He holds a BSc, Grad Dip (Psychol), and PhD from Australian universities. His research focuses on brain development, psychiatric disorders (e.g., ADHD, schizophrenia), substance use in youth, and neurobiological interventions like ketamine treatments. He oversees the Longitudinal Adolescent Brain Study (LABS), tracking brain development and mental health predictors in adolescents.

• Deputy Director, Thompson Institute
• Program Coordinator: Mental Health and Neuroscience postgraduate programs

Research Interests: Adolescent neurobiology, mental health biomarkers, neuroimaging (EEG, MRI), and clinical trials for mood disorders. His work includes studying ketamine's effects on suicidality and alcohol-induced brain impairments.

Articles Trends: Recent works emphasize cyberbullying neurophysiology, ketamine treatment efficacy, and brain structure correlates of mental health in youth. His research often integrates multimodal data (neuroimaging, cognitive assessments) to identify early biomarkers for disorders.

• Awards: 2023 Excellence in Supervision Award, NHMRC grants, Early Career Awards

Grants/Supervision: Secured over $7.3M in grants, supervised >30 HDR students. Current projects include ketamine trials for depression and ketamine/zinc treatments for anorexia nervosa.

Labs/Teams: Thompson Institute's Youth Mental Health group, collaborating on projects like the LABS cohort and neuroimaging studies.